Results 121 to 130 of about 4,565 (213)

Wide dissemination of Gram-negative bacteria producing the taniborbactam-resistant NDM-9 variant: a One Health concern [PDF]

, 2023
Buchs, Chloé, Castanheira, Mariana, Di, Doris Yoong Wen, Le Terrier, Christophe, Nordmann, Patrice, Poirel, Laurent, Rossolini, Gian Maria, Stephan, Roger   +7 more
core   +1 more source

Η εφαρμογή του νέου αναστολέα vaborbactam στη θεραπευτική των λοιμώξεων

, 2022
Οι λοιμώξεις από ανθεκτικά στις καρβαπενέμες Enterobacterales, Pseudomonas aeruginosa, και Acinetobacter baumannii αποτελούν απειλή για τη δημόσια υγεία παγκοσμίως, και σχετίζονται με αυξημένη νοσηρότητα και θνητότητα. Η αντοχή οφείλεται κυρίως στην παραγωγή καρβαπενεμασών. Η βαμπορβακτάμη είναι ένας νέος αναστολέας β-λακταμασών.
openaire   +1 more source

Aminoglycosides enhance meropenem/vaborbactam activity against KPC-producing <i>Klebsiella pneumoniae</i> in the hollow fiber infection model. [PDF]

Antimicrob Agents Chemother
Singh N, Jogan CML, Zang Y, Shan X, Lang Y, Karunanidhi A, Watkins JV, Curry BN, Tamma PD, Nozick SH, Ozer EA, Hauser AR, Bulitta JB, Bulman ZP.   +13 more
europepmc   +1 more source

Increased blaKPC Copy Number and OmpK35 and OmpK36 Porins Disruption Mediated Resistance to Imipenem/ Relebactam and Meropenem/Vaborbactam in a KPC-Producing Klebsiella pneumoniae Clinical Isolate [PDF]

, 2022
Bianco, Gabriele, Boattini, Matteo, Costa, Cristina   +2 more
core   +1 more source

Complete genome sequences of KPC-producing <i>Klebsiella pneumoniae</i> isolates pre- and post-development of meropenem/vaborbactam resistance. [PDF]

Microbiol Resour Announc
Ozer EA, Nozick SH, Singh N, Watkins JV, Hauser AR, Bulman ZP.   +5 more
europepmc   +1 more source

Cefiderocol in the Successful Treatment of Complicated Hospital-Acquired K. pneumoniae NDM, OXA48 Intraabdominal Infection

Infection and Drug Resistance
Ignacy Tarski,1 Jakub Śmiechowicz,2 Wiesława Duszyńska2 1Faculty of Medicine, Wroclaw Medical University, Wroclaw, Poland; 2Department and Clinic of Anesthesiology and Intensive Therapy, Wroclaw Medical University, Wroclaw ...
Tarski I, Śmiechowicz J, Duszyńska W
doaj  

Impact of loading dose β-lactam therapy on outcomes of KPC-producing Klebsiella pneumoniae bloodstream infections in non-ICU patients: a real world study. [PDF]

J Antimicrob Chemother
Frallonardo L, Guido G, De Gennaro N, De Iaco G, Signorile F, Cibelli M, De Luca A, Ritacco AI, Stolfa S, Di Gennaro F, Saracino A.   +10 more
europepmc   +1 more source

Unlocking potentials: the impact of meropenem, meropenem-vaborbactam, and ceftazidime-avibactam in combating carbapenem-resistant Enterobacter cloacae. [PDF]

Antimicrob Agents Chemother
Lavoie T, Sierra T, Daffinee K, Pogue JM, Achour B, LaPlante K.   +5 more
europepmc   +1 more source

Two Comprehensive Liquid Chromatography High-Resolution Mass Spectrometry (UPLC-MS/MS) Multi-Methods for Real-Time Therapeutic Drug Monitoring (TDM) of Five Novel Beta-Lactams and of Fosfomycin Administered by Continuous Infusion. [PDF]

Pharmaceutics
Trozzi I, Giorgi B, De Paola R, Gatti M, Pea F.   +4 more
europepmc   +1 more source

Correction: Molecular resistance mechanisms to newly approved antibiotics (2017-2025) in WHO priority pathogens. [PDF]

Front Microbiol
Frontiers Production Office.
europepmc   +1 more source